Related Experiment Video
Updated: Jul 27, 2026

Measuring the Subjective Value of Risky and Ambiguous Options using Experimental Economics and Functional MRI Methods
Published on: September 19, 2012
Assessing Risk Acceptability and Tolerability in Italian Tunnels with the Quantum Gu@larp Model
Massimo Guarascio1, Emin Alakbarli1, Carlota Despabeladera1
1Faculty of Civil and Industrial Engineering Sapienza, Via Eudossiana 18, 00184 Rome, Italy.
Abstract:
Road tunnels are associated with numerous risks including traffic accidents and fires, posing threats to individual or group users. Key risk indicators such as Risk Quantum, Individual Risk, Societal Risk, and Expected Number of Fatalities are instrumental in evaluating the level of risk exposure. These indicators empower Rights-Holders and Duty-Holders to report hazards, prevent disasters, and implement timely remedial measures. A crucial indicator, the Scenario Risk Quantum, has its roots in the forensic evaluation of responsibility in a fatal tunnel accident in the UK since 1949. The Quantum of Risk of each design scenario, reasonably selected among rational and practicable possibilities, has both a deterministic and probabilistic character. The Risk Tolerability and Acceptability criteria are modelled according to risk indicators by selecting the parameters according to ethical principles and societal policy. Scenarios are meticulously identified, described, probabilised and assigned probabilities prior to the quantitative risk analysis. These risk indicators are integral to the risk assessment process. This article delves into the understanding of these indicators within the context of Italian road tunnels, employing the Quantum Gu@larp Model to analyse Risk Acceptability and Tolerability.
More Related Videos
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

